Strasbourg, France

Jerôme Wagner

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Institut Polytechnique De Bordeaux, Universitë De Bordeaux. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jerôme Wagner. Retrieved from https://idiyas.com/inventor/jerôme-wagner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jerôme Wagner: Innovator in Antimicrobial Peptides

Introduction

Jerôme Wagner is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of antimicrobial agents through his innovative research and development. His work focuses on the creation of fusion peptides that serve as effective antimicrobial agents.

Latest Patents

Wagner holds a patent for "Fusion peptides as antimicrobial agents." This invention relates to a fusion peptide characterized by specific formulae, including P1-L-P2 and P2-L-P1. The peptide incorporates proline-rich antimicrobial peptides and a Lisa peptide linker, demonstrating potential in combating microbial infections.

Career Highlights

Throughout his career, Jerôme Wagner has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Strasbourg. His research has contributed to advancements in the understanding and application of antimicrobial peptides.

Collaborations

Wagner has collaborated with notable colleagues, including Dominique Burnouf and Gilles Guichard. These partnerships have further enriched his research endeavors and expanded the impact of his work in the scientific community.

Conclusion

Jerôme Wagner's contributions to the field of antimicrobial peptides highlight his innovative spirit and dedication to scientific advancement. His patent and collaborations reflect his commitment to improving health through research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…